USFDA auditors have inspected Shilpa Medicare Ltd’s manufacturing facilities located at Deosugur Industrial Area, Deosugur, Raichur (Karnataka).
The auditors have also inspected its 100 per cent EOU facility at Raichur Industrial Growth Centre, Wadloor Road, Chicksugur Cross, Chicksugur, Raichur (Karnataka).
The company in a release to exchanges said that the results of the audit are awaited.
Business Line
By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…
Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…
New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…
National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…
Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…
New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…